ARTICLE | Clinical News
MedImmune Inc., Micromet AG preclinical data
August 8, 2005 7:00 AM UTC
Researchers published in Cancer Immunology Immunotherapy that 0.06 µg/kg of MT103 led to fully reversible activation of T cells in chimpanzees. Also, repeated short-term exposure of MT103 led to a cum...